Canada
· Delayed Price · Currency is CAD Medicure Statistics
Total Valuation
Medicure has a market cap or net worth of CAD 9.18 million. The enterprise value is 3.74 million.
| Market Cap | 9.18M |
| Enterprise Value | 3.74M |
Important Dates
The last earnings date was Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Medicure has 10.44 million shares outstanding. The number of shares has decreased by -1.16% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 10.44M |
| Shares Change (YoY) | -1.16% |
| Shares Change (QoQ) | -0.57% |
| Owned by Insiders (%) | 25.26% |
| Owned by Institutions (%) | 0.62% |
| Float | 5.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.44 |
| PB Ratio | 0.47 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.42 |
| EV / Sales | 0.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.87 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -55.02 |
Financial Efficiency
Return on equity (ROE) is -12.90% and return on invested capital (ROIC) is -7.72%.
| Return on Equity (ROE) | -12.90% |
| Return on Assets (ROA) | -5.63% |
| Return on Capital (ROIC) | -7.72% |
| Revenue Per Employee | 550,842 |
| Profits Per Employee | -69,211 |
| Employee Count | 38 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 2.28 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.68% in the last 52 weeks. The beta is 0.90, so Medicure's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -45.68% |
| 50-Day Moving Average | 0.94 |
| 200-Day Moving Average | 1.14 |
| Relative Strength Index (RSI) | 41.70 |
| Average Volume (20 Days) | 1,855 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicure had revenue of CAD 20.93 million and -2.63 million in losses. Loss per share was -0.25.
| Revenue | 20.93M |
| Gross Profit | 12.85M |
| Operating Income | -2.59M |
| Pretax Income | -2.54M |
| Net Income | -2.63M |
| EBITDA | -887,000 |
| EBIT | -2.59M |
| Loss Per Share | -0.25 |
Balance Sheet
The company has 5.85 million in cash and 402,000 in debt, giving a net cash position of 5.45 million or 0.52 per share.
| Cash & Cash Equivalents | 5.85M |
| Total Debt | 402,000 |
| Net Cash | 5.45M |
| Net Cash Per Share | 0.52 |
| Equity (Book Value) | 19.54M |
| Book Value Per Share | 1.87 |
| Working Capital | 7.36M |
Cash Flow
| Operating Cash Flow | 1.15M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 61.41%, with operating and profit margins of -12.35% and -12.56%.
| Gross Margin | 61.41% |
| Operating Margin | -12.35% |
| Pretax Margin | -12.12% |
| Profit Margin | -12.56% |
| EBITDA Margin | -4.24% |
| EBIT Margin | -12.35% |
| FCF Margin | n/a |
Dividends & Yields
Medicure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.16% |
| Shareholder Yield | 1.16% |
| Earnings Yield | -28.64% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 2, 2012. It was a reverse split with a ratio of 0.0666666.
| Last Split Date | Nov 2, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.0666666 |
Scores
Medicure has an Altman Z-Score of -1.61. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.61 |
| Piotroski F-Score | n/a |